Dioniz Vysocki1, Lukas Pilipavičius2
1Vilnius University, Faculty of Medicine, Vilnius, Lithuania
2Karoliniškės polyclinic, Vilnius, Lithuania
Abstract
Background. Attention deficit hyperactivity disorder (ADHD) is a mental disorder that starts in childhood and is characterised by increased activity, attention deficit and impulsivity. Over the last decade, the number of drugs prescribed to treat ADHD has increased significantly, leading to increasingly high costs for healthcare systems. Given the economic aspect and the most relevant assessment – patient health, it is important to evaluate the impact of pharmacotherapy on the quality of life of adults with ADHD.
Aim. To conduct a review of literature on attention deficit hyperactivity disorder in adults, discussing the impact of drug treatment on their quality of life.
Methods. A literature review was conducted on the PubMed database, using the keywords: „attention deficit hyperactivity“, „ADHD“, „medication therapy“, „quality of life“, „adult“. Articles published in the last 10 years in English were selected for the analysis.
Results. All medications studied for adult ADHD treatments in clinical trials improved patients‘ quality of life compared to placebo, and pharmacotherapy has been assessed as a significant factor in the quality of life of those taking it.
Conclusions. When comparing a group of adults with ADHD on medication with a group of adults with ADHD on no medication, the former group showed significantly better quality of life scores. Pharmacotherapy was assessed as an important factor in the health of patients with ADHD and is indicated to be used in combination with other non-pharmacological treatments.
Keywords: attention deficit hyperactivity, medication treatment, quality of life, adult pharmacotherapy.
https://doi.org/10.53453/ms.2024.5.2
Quality of life differences between attention deficit hyperactivity
disorder diagnosed adults with and without medication treatment
– literature review
Dioniz Vysocki
1
, Lukas Pilipavičius
2
1
Vilnius University, Faculty of Medicine, Vilnius, Lithuania
2
Karoliniškės polyclinic, Vilnius, Lithuania
Abstract
Background
!
Aim"!
Methods!!#$%!&'
('('(' ('()*
+!
Results,
%
Conclusions-!!!
! #!
!
!.
Keywords&
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
Medical Sciences 2024 Vol. 12 (3), p. 8-17, https://doi.org/10.53453/ms.2024.5.2
8
Suaugusiųjų, turinčių aktyvumo ir dėmesio sutrikimą, gyvenimo
kokybės skirtumai vartojant ir nevartojant medikamentinio
gydymo – literatūros apžvalga
Dioniz Vysocki
1
, Lukas Pilipavičius
2
1
Medicinos fakultetas, Vilniaus universitetas, Vilnius, Lietuva
2
Karoliniškių poliklinika, Vilnius, Lietuva
Santrauka
Įvadas%/%0%/1%%2%
/1%/%"34/4%%4
% 5 414 1 #617 27 %2 /1 %% 4
22402%3837%7
%6 %6 77 4 %6 7 %4 %7 0 94
414%%
Tikslas% 414%/%836 %
%714%%
Metodika:82%%'#$(4;/11%33&'%/
%('%('%%/('414(<2%/824
%6%9%1%%)*44%
Rezultatai 0414 % / % %% 2
%%%%777=
%7%%63&>%44
0 1 % 4 %%?
%17%%2%1619414%%
Išvados. #%%/%4794%6
:414940194%76?414940
194%/%%/79%2
@%17%%0944%%
%%%8
Raktažodžiai: % / % % %%/ 414
%1
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
9
1. Įvadas
% / % 0
%/1 /
8%/ 2% /1 %
/ % "
? % % 1
%5414)>
0 3 ;1
/ 1& %
%414341
/ % A B / %
/19;144%4
%4%9 / %
0 3 ;1 7
4 0 %%
.;15"
%%? % 3
/1 % / 7
% ;1 3 %6
/1 %%1 %
3.3 94 %1
./1 32
2.2% C 0
/1 %
%3%/ 3
% ;% 8
%
%/%//783D
=% %/ 1
3 24 4 4 ;%6
0 9414
%4%6%76
E F 7 %
0 9
0.%6
/%66G9
%617.27 /1 1
4 %7 0 1
%%2798
%29 ;%. %
7 0% 38
% 2 0 ;
%3
8 617 27
%2 /1 %% 4 224
0H2
%38I A*)I 4
% 38
%% 0 91 %
)D** +JK 0 9
# 2 2 %
4
4 %1 B%
%414 34 1
%%%
3 0 94 4
2/44%/%
AH**+JK)*"/
%2 2 %23/ 14
414 )H.5*L 194 %.
7 6 /1 M
424%38
22 3 /3/1
4 14
/ F= 2
% 1 4 )) 3 7
2 % % %6
774%67.
%4 %7 0 94 414
%%
2. Metodika
:8 3 % /1
4 ;/1 '#$( #2%
%33&'%/%(
attention deficit hyperactivity disorder
'0(LADHD'%.
( medication treatment'
%%/( quality of life '414(
Ladult'%1(pharma-
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
10
cotherapy % 6 %9
%1 2 4 %
% A*)C.A*AC 3 7
%1 21 8 31
DD.%
3. Rezultatai
3.1. Gydymo galimybės
+ 414 0 %
European Network Adult ADHD, +B
19AH+%.
1 0 9 .
8 %
%16 %16 %?
16>+"0%)A
#2 6 3 7
0 1
1 " AEL8% 4 0
/ .
A5L)CL)CL
14314%
5CL % AAL
)DL%4341
%)5B9%.
1
? % % %
#;3 ;/ %
% 1 %3
%./ 3
%
% 8
% 0
% % 1
K%%/%%
2 %16
8 1 1
;6 6
% 8 %4
94 %%4 4 %
14 1 1
%81 %/1 1
%38%?9
4 %4 %%?
? ? @ )GI N )II) O
***))C )D # % /
%7613?
2%9 %
.)E
#21%.
% %/ /
% /
6
%6)G % 7
1 1 %
% %
1 0BK< %
%.
)H = A*)H
% .;/ )I
1%0
. %
amphetamines $#
."4$#%
%1
;1A*
A) F4 % % 2%
4 % % 4 %
% 38
1/1%D)I*
% />
% >+"
%2 ; % $#
%
%. % % %
% 1
% % %/ %
%.1 % 7 /%
3/1?%2%%
I5;
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
11
AA.AC>44%6
6 $# >+" %2
;%H514ADP
% 31 DE
%%
7 % ; 0
%1";%
0%%9 couching
%4 783
%81.%/AE
3.2. Gyvenimo kokybės rodikliai
= % %7
4 %%
3 7
%01%
% %4 %
%AG34%
AH / AI /
5* ; 2
%5)
% 7% /
%4/14.AE%
/ %/ %
5A %
%1%155
% %./ %
335C4/2
2%95D:
% 1 /1? 4
3314%95E5G
/1? % 5H %
%/%4%43;
5I"4%4/%
%$#%%
2 & 7%4
% 1
DH3/1;%C*
% % %.
% 5H 32% %
C)1CA%434
1 % C5 Q %
/ 0 9 3
/%2$#
% 2% 0 =
%7 % % %
% % %
% 8 %
% CAL 5HL %
CACC #/1 %/%
% 3 1
% 1
%2 3/1 %/ ;%
5)L CD 03/1 %.
;% 4 %4
34 34 /24 4
%4 34 1 CE
03/1 32% %
3443%
;% %2 3/1 4
194 $# A) C)
= 4 %4 37
%9 4 31
%483%%
%1 / CG CH %
% 4 3
47914%4%94
CI #/1? %
3%
%6 % 37 %4
3778337
1%4 / 16 D*.D5 #
% %4
94%/1%%/
DC % %1
04 .;4
%7 6 19
0 9
% 19
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
12
%2 %
%%414DDA*A5
.;/1$#
H*/142
%433/1DD%A)
5C 24 4
0 94 4
%%/ % %
0 9 %1
.19 414 3 E
/ /
%21 2
4 .%4 2
3/ %/
%4 34 1%
% %
=% % %
2 $# /
%.67
4.9Išvados
% / %
9 %
1 2
%1 %%/
%4#194
% % %
% % % 4
1%%1>+"
%1%
Literatūros šaltiniai
) F @! >L#
R0.KS
: B 0 R LF
LA*)DTAAA&)I)A**
A >;$M%"0R%%#K
@ > :F
&
M$R#A*)G
AAT)G)&5*A
5 >; $ M% " R%% #
@ > : K& .
S
URF#A*)ETE))&E*
)
C : @ 0= 0 "F
M # 0 > KR "
< F $
#KA*)G$TAE)&)DDD
D FK : .$
0V-FA*)I"
&
+#E)&C)CH
E M 0 $ @ K
-! >W - " @ 0=
M F A*A* !
.
F
#K)A5&A)5*
G R;@R0B
F : # .
!
& .! + M $
A*)G@TA*)&C.))
H $% K # 0 X F
MK"#
$R#R
FA*A*FTACA&5*).5*H
I + F F
>0++RR0RM
Y 0% M "% +
R1% $ $ -
#
&
!!%.#:0
A*A*A)T)D)*&*AC*DHC
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
13
)* :;% M :! 0 $ $
F K K R
+#A*)I$TDH&5H.CC
)) M A*)I $
R
)AA*C
)II*.A*)I&
M0
A*)I : # A*AA @TIA&)5G.
)D*
)A >1 FF0 M1 0 :
F%KM<MZ;F"F
> 0 B @ R 0 0 $ #
:[[%0R$MF$F$
K=>1##
B0M0MM.
M + M -%
0%+#$B@R
$<$<<0"
>F@FK.XF@%
>K@$$@;
$$:$$$%B
M%!;##"#!#
R #F K # K
$%% 0% 0 # 0 W 0
M1 0 : " >! F $\.
0!%J%%"#=
W@]Z;Y.#$#
#J+R0
+
#A*)I@TDE&)C.5C
)5 @ F 0 B ! <
!%".^0.;!
: M
@01F$R>
+:0B.$@_B0#
M+ #;; $ #.= F" $
" W ` $ Y% $ >
KRT - - $ 0
R"
0$.<= -
; - $ 0
A*)G
$TI)&CG.ED
)C %%"-+:a"
Ma0F%FR.
!
#+0J0&
A*)D
$TG)&HI.II
)D %%":a"RF
- + F% F Ma 0
# !
#+0J0&
; + #
A*)GFTCC&)C).)DA
)E + F F
>0++RR0RM
Y 0% M "% +
R1% $ $ -
#
&
!!%.#:0
A*A*A)T)D)*&*AC*DHC
)G M.bMBF
$#M;0R
$\JBF0#0>0.
M% + W 0FT M
# +.
&
M
# F
#A*)C$TAH5&)GI.A*5
)H #MF@0=
K:.
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
14
& % :
#A*)EFT5E&DEH.GH
)I R0BR
$.FRFR0%
:Y " : M!% " R
R 0 + Y M R
#$0R0%@`
F R R
.
& ! !%
. : # A*)H
0TDI&GAG.G5H
A* >$M%">K@
F$ - 0 : .&
. F
#A*)I0TA5G&G55.CC
A) R`M.0:R
K
R 0 K A*)H
ITHH&R**GH)5
AA #F"+$
0M#R$!::
FR c.:00%+ M
0.0$K$K;-K;.
F#>M.$
=$>RM\#+
<0$M$";
+ :T R $
# 0
R$#0 R +
# < R
$#"
.S
&K;R"F$
#A*)DTGA)A&))II.A)*
A5 W0+M0F@
>% $ #.- @
M1
;
.
. !
+
# R B A*)G
TAEG5&AEG.AGE
AC F R$ M: FV
>F0$R
& !
.
A*)E$TH)&5.))
AD :+%#R>
F W 0 +
.
.S &
! #:0 A*)D @
ADT)*A&*))EC*G
AE R $ $ RF "
+$.M"
&$.K!F
A*A*$TACD&EAG.EC5
AG 1M1B$
@ < $
K M!
< F
A*)EFTA*E&D)*.H
AH @% $ $
+- > @0=#% +
R
! .
A*)CFTEA&HG.
II
AI K R F K >
R"@
& .
MFR#A*)G
$TDE)&55.DA
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
15
5* ; K # "@ +$
R^0$M0#-+F
@ W !
R F R #
A*)ETCCE&)A)G.AI
5) M$!$#;<M
:0\".F0;%K
$\ K $ $" "
-MR<
&"!
.FMA*)G
)TEC&CI*.D*C
5A 0d0:%
F@$#M#$$
!
& !
: A*)D $
5*T5HDIIH5&A)I*.E
55 $0$;F<
!+M!0#R.
S #
< # =; W
- F R # A*)E
FTCC)&)DD.EE
5C > 0 F W F"
R00:
M%- K%
%
!!
A*)CB)T)CC&G*.G
5D R Y : # _
M$ R>1.%K01a
:$%
& .
< F + A*)C
TC5E&)H)D.AC
5E @;%>"F
A*)C
0TE5&)D5.H
5G 0!+B!+M!0#
#! .
!!!&
^ F R
##A*)C$TDDD&D*D.)D
5H M 0 $ @ K
-! >W - " @ 0=
M F ! .
F#KA*A*
T)A5&A).5*
5I M;B0$>F
# $ !
.S
BMKA*)H0TIA&CEC.CGE
C* R Y : # _
M$01a:0
!
.S
&.
F$#A*)C$TG)5&5)I.AD
C) R X 01a K M
_M$:#:
.S
&
M$FA*)CF)HT5CH&5GEI
CA RY_M$X#
: # : $
.S
K% & B!
: R 0 M #
A*)E)DTH*)A&I)E.IAA
C5 RY:#:
_M0+@;0:ea
B:0
% F R #
#A*)CTDDH&HGH.HD
CC -:F0WRW00WRF
W >R : ": : 0W.
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
16
% &
!."!F
#KA*)EFTGA&E.)C
CD RY:#:
_M0+@;0:ea
B:0
% F R #
#A*)CTDDH&HGH.HD
CE $.F R $\ M R
M 0> 0 R .
S R
K% R
W B!
0 F R #
A*)ITDHC&CC5.CDA
CG :WF-"R$F-
>:MW$0"#:R"WR
"0F:-RR"FK%"
M<1R
W - .
"! F
A*)HTE5A&A55.A5H
CH $ K$ " 0$ #
R K% <1
R
$ < $ "
#A*)E$TCIA&CD.D*
CI : W 01a Ra $
_ M$ R :
: # M!
$ J #
++"<-
.S
F$#A*)G)TGCH&H)D.HAA
D* 0 >1 FF A*)H .
< K 0^ <&
F + 0 0^
$<#"
0^ $ 0
R
D) $ $ R1 R
$F01+FM%"F>1
FF"!
. F A*)D
$T)ID&5EH.GI
DA = $;; : K F#
>F%#:."
&0K! 0.+
0 @ F A*)E
TA*C&AID.5*D
D5 0%>"%
K% = > W
.S
K A*)G
$TEA&))D.)A5
DC $ !.M FR
$!"$"+:
0X&:@
R + "!
R F R R # A*)G
$.TCEA&AHC.AIC
DD >K$FK>
FKF@<
-<
# " F
A*A5$TAGG&EEI.EIG
Journal of Medical Sciences. 5 May, 2024 - Volume 12 | Issue 3. Electronic - ISSN: 2345-0592
17